CN Patent

CN112159391A — 治疗活性化合物的药物组合物

Assigned to Les Laboratoires Servier SAS · Expires 2021-01-01 · 5y expired

What this patent protects

本发明提供了用于治疗癌症的化合物和药物组合物及治疗癌症的方法，所述方法包括向有需要的受试者施用本文描述的化合物和药物组合物。

USPTO Abstract

本发明提供了用于治疗癌症的化合物和药物组合物及治疗癌症的方法，所述方法包括向有需要的受试者施用本文描述的化合物和药物组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN112159391A
Jurisdiction
CN
Classification
—
Expires
2021-01-01
Drug substance claim
No
Drug product claim
No
Assignee
Les Laboratoires Servier SAS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.